| (USD) | Jun 2026 | Y/Y change |
|---|---|---|
| Revenue | 0.00 | — |
| Operating expense | — | — |
| Net income | -3.13M | — |
| Net profit margin | — | — |
| Earnings per share | — | — |
| EBITDA | — | — |
| Effective tax rate | — | — |
Over the past year, INKT returned -18.1% with dividends reinvested.
| Period | Total return |
|---|---|
| YTD | +9.4% |
| 1 year | -18.1% |
| All-time high | $178.90 (Oct 2021) |
Returns are total returns and include reinvested dividends. The all-time high is the highest monthly closing price on record.
See what $1,000 in INKT would be worth today ›No. MiNK Therapeutics, Inc. has not paid a dividend in the past 12 months.
MiNK Therapeutics, Inc. stock trades on NASDAQ under the ticker symbol INKT.
MiNK Therapeutics, Inc. is part of the Healthcare sector.
MiNK Therapeutics, Inc. has a market cap of 62.26M USD, based on the latest quote.
MiNK Therapeutics, Inc. is scheduled to report earnings on Nov 12, 2026.
